So HBM3E, first of all, it's a great product. As I mentioned well received by our customers, high-performance, and 30% lower-power than any other product that's out there. So of course it has strong demand and as we have highlighted, we are sold out for our calendar year '24 supply and calendar year '25 supply is also mostly vast majority is already allocated. We are -- we have just begun production shipments, and these will continue to increase through the course of calendar year '24, as well as continue to increase through calendar year '25. We are continuing to work on increasing our capacity and making good progress with respect to capacity as well as overall yield and quality. So certainly, in calendar year '25 versus calendar year '24, given that we are just starting our production here now, will certainly be a significant growth over our calendar year '24 numbers. And you can look at it the same way for fiscal '24 versus '25, so it will be definitely a significant increase with us, achieving our shares in HBM, in line with our industry share, sometime in calendar '25. I'm not in a position to spell it out exactly for you in terms of what is the volume increase, but certainly HBM with our strong product position, it will be a strong driver of revenue growth, fiscal year '24 -- fiscal year '25 or fiscal year '24. Regarding the wafer capacity by end of this fiscal year, we have said low double-digit structural reduction in capacity. And of course, we will be managing this capacity in fiscal year '24, keeping in mind our focus on supply-demand discipline, I was staying extremely disciplined with respect to supply growth, staying extremely disciplined with respect to our HBM share as well. And advantaging our technology transitions, as we go through the year. And our CapEx in '25 -- well, in fiscal '25 will be higher than fiscal '24. WFE will be higher as well. And of course, construction CapEx related to the Greenfield that is required for the second half of the decade will contribute to some of the CapEx increase in fiscal '25. But some of those details we'll provide you as we get closer to fiscal year '25. So, most important thing is that we will manage our wafer capacity technology transitions to really maintain our bit share, that is part of our strategy to have stable bit share even with increasing penetration of HBM. And again, just keep in mind that our overall framework of our CapEx being 35% of our revenue across the cycles still applies.